1. Home
  2. UGRO vs DOMH Comparison

UGRO vs DOMH Comparison

Compare UGRO & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UGRO
  • DOMH
  • Stock Information
  • Founded
  • UGRO 2014
  • DOMH 1967
  • Country
  • UGRO United States
  • DOMH United States
  • Employees
  • UGRO N/A
  • DOMH 28
  • Industry
  • UGRO Industrial Specialties
  • DOMH Biotechnology: Pharmaceutical Preparations
  • Sector
  • UGRO Consumer Discretionary
  • DOMH Health Care
  • Exchange
  • UGRO Nasdaq
  • DOMH Nasdaq
  • Market Cap
  • UGRO 8.8M
  • DOMH 74.9M
  • IPO Year
  • UGRO N/A
  • DOMH N/A
  • Fundamental
  • Price
  • UGRO $0.73
  • DOMH $11.94
  • Analyst Decision
  • UGRO Strong Buy
  • DOMH
  • Analyst Count
  • UGRO 2
  • DOMH 0
  • Target Price
  • UGRO $5.63
  • DOMH N/A
  • AVG Volume (30 Days)
  • UGRO 130.2K
  • DOMH 4.1M
  • Earning Date
  • UGRO 03-26-2025
  • DOMH 03-31-2025
  • Dividend Yield
  • UGRO N/A
  • DOMH N/A
  • EPS Growth
  • UGRO N/A
  • DOMH N/A
  • EPS
  • UGRO N/A
  • DOMH N/A
  • Revenue
  • UGRO $70,320,066.00
  • DOMH $12,589,000.00
  • Revenue This Year
  • UGRO $17.15
  • DOMH N/A
  • Revenue Next Year
  • UGRO $21.76
  • DOMH N/A
  • P/E Ratio
  • UGRO N/A
  • DOMH N/A
  • Revenue Growth
  • UGRO 12.08
  • DOMH 1117.50
  • 52 Week Low
  • UGRO $0.60
  • DOMH $0.83
  • 52 Week High
  • UGRO $2.84
  • DOMH $13.58
  • Technical
  • Relative Strength Index (RSI)
  • UGRO 36.76
  • DOMH 82.78
  • Support Level
  • UGRO $0.66
  • DOMH $6.31
  • Resistance Level
  • UGRO $1.12
  • DOMH $13.58
  • Average True Range (ATR)
  • UGRO 0.12
  • DOMH 1.72
  • MACD
  • UGRO 0.01
  • DOMH 1.00
  • Stochastic Oscillator
  • UGRO 25.05
  • DOMH 86.16

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.

Share on Social Networks: